Skip to main content

Want a detailed portfolio tracker?

Anavex Life Sciences (AVXL) P/E (2010 - 2026)

Anavex Life Sciences (AVXL) P/E from Sep 30, 2010 to Jun 3, 2026. The TTM Anavex Life Sciences (AVXL) P/E is -5.74. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Anavex Life Sciences (AVXL)

YearP/EChange
2026-5.74-25.70%
2025-7.72-60.47%
2024-19.54+24.21%
2023-15.73+5.35%
2022-14.93-52.71%
2021-31.57+160.19%
2020-12.13+133.82%
2019-5.19+45.95%
2018-3.56-64.73%
2017-10.08+5.30%
2016-9.58+0.40%
2015-9.54+198.54%
2014-3.19-82.22%
2013-17.97+975.73%
2012-1.67-31.52%
2011-2.44-69.68%
2010-8.04N/A

Comparison Anavex Life Sciences (AVXL) P/E with competitors

Anavex Life Sciences (AVXL) P/E is -5.74.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.03%
NBYStablecoin Development Corp0.10-101.78%
ENLVEnlivex Therapeutics Ltd0.15-102.62%
FGENFibroGen Inc0.24-104.18%
TRAWTraws Pharma Inc0.47-108.24%
FBIOFortress Biotech Inc0.71-112.30%
CHRSCoherus Biosciences Inc0.98-117.05%
ORMPOramed Pharmaceuticals Inc1.47-125.68%
AGENAgenus Inc2.05-135.70%
VIVSVivoSim Labs Inc2.54-144.19%
INVAInnoviva Inc3.19-155.57%
CRMDCorMedix Inc3.65-163.54%
ABEOAbeona Therapeutics Inc4.20-173.28%
VXRTVaxart Inc4.26-174.27%
CVACCureVac N.V.4.45-177.48%
SRPTSarepta Therapeutics Inc4.62-180.59%
GLPGGalapagos NV4.86-184.68%
RIGLRigel Pharmaceuticals4.92-185.74%
ZVRAZevra Therapeutics Inc4.97-186.69%
ABUSArbutus Biopharma Corp5.69-199.23%
CGENCompugen Ltd7.38-228.69%
AUPHAurinia Pharmaceuticals Inc9.25-261.23%
ACADAcadia Pharmaceuticals Inc9.59-267.10%
OMEROmeros Corporation9.88-272.25%
PLXProtalix BioTherapeutics Inc9.91-272.70%
SPROSpero Therapeutics Inc10.73-287.08%
ADMAAdma Biologics Inc11.33-297.47%
SVASinovac Biotech Ltd11.44-299.31%
TBPHTheravance Biopharma Inc11.78-305.24%
HRMYHarmony Biosciences Holdings Inc12.18-312.28%
TGTXTG Therapeutics Inc13.18-329.69%
INCYIncyte Corp13.38-333.22%
SABSSAB Biotherapeutics Inc14.06-345.00%
XOMAXOMA Corp14.95-360.47%
REGNRegeneron Pharmaceuticals Inc14.98-361.08%
PBYIPuma Biotechnology Inc15.05-362.30%
EXELExelixis Inc15.79-375.27%
NAGENiagen Bioscience Inc16.35-385.03%
CPRXCatalyst Pharmaceuticals Inc17.34-402.29%
MDXGMimedx Group Inc17.38-402.82%
ARGXArgen X SE23.07-502.09%
HALOHalozyme Therapeutics Inc23.20-504.34%
XOMAOXOMA Corp25.34-541.71%
VRTXVertex Pharmaceuticals Inc25.66-547.13%
XOMAPXOMA Corp25.67-547.38%
CTMXCytomX Therapeutics Inc25.70-547.86%
ASNDAscendis Pharma A/S26.35-559.30%
RPRXRoyalty Pharma plc - Class A27.50-579.19%
SLNOSoleno Therapeutics Inc29.02-605.68%
LGNDLigand Pharmaceuticals Inc - Class B30.19-626.09%
BMRNBiomarin Pharmaceutical Inc37.51-753.68%
APLSApellis Pharmaceuticals Inc39.02-780.06%
KRYSKrystal Biotech Inc39.70-791.85%
GMABGenmab40.20-800.67%
ONCBeiGene Ltd67.03-1268.15%
TECHBio-Techne Corp68.59-1295.48%
VCELVericel Corp80.63-1505.21%
PHARPharming Group N.V.87.74-1629.14%
ALNYAlnylam Pharmaceuticals Inc124.93-2277.35%
TLXTelix Pharmaceuticals Ltd139.89-2538.03%
CORTCorcept Therapeutics Inc158.39-2860.42%